Vancouver, Canada (May 19, 2022) – GenXys Health Care Systems, Inc., the global leader in precision prescribing software with embedded pharmacogenetic data, recently finalized another customer deal to advance precision medicine initiatives with Ohio-based Flexsus, the laboratory division of FlexHealth. Combined…
To improve the usability of TreatGx, our Urinary Tract Infection treatment algorithm has been split into individual conditions: Urinary Tract Infection – Cystitis (Empiric therapy) and Urinary Tract Infection – Pyelonephritis (Empiric therapy). The greatest advantage to users is that there…
Dr. Nita Limdi is a Professor at the University of Alabama at Birmingham. She is a clinical pharmacist, epidemiologist, and renowned researcher in pharmacogenomics and pharmacoepidemiology. Her research centers around the factors that influence drug responses, with a focus on anticoagulants…
Vancouver, Canada (May 13, 2022) – Innovation and differentiation continue to propel precision prescribing software company GenXys with accolades and commercial success in the US market. GenXys recently was named the 2022 Best Overall Medical Data Solution Provider by MedTech Breakthrough…
Pharmacogenetic Testing & EHR Integration Help Avoid Trial-and-Error Prescribing Vancouver, Canada (April 21, 2022): GenXys Health Care Systems, Inc., the global leader in precision prescribing software with embedded pharmacogenetic data, added a record five pharmacogenetic companies as customers in the first…
Adverse Drug Events (ADEs) annually account for more than 1 million emergency department visits, 2.2 million hospital admissions, 3.5 million physician office visits, and $136 billion in U.S. health care costs. In addition to being the #1 most costly hospital-acquired condition,…
This update accounts for revisions made to existing clinical guidelines and will help health care providers select the safest and most effective medications with their patients. This update follows the recommendations from the 2019 American College of Rheumatology Foundation Guideline for…
All TreatGx users now have access to the updated treatment algorithm for Chronic Obstructive Pulmonary Disease (COPD) – Stable. As always, this update includes the TreatGx standard of providing personalized dosing based on any applicable pharmacogenetics, kidney function, liver function, and…
References 1 – https://www.futuremedicine.com/doi/10.2217/pgs-2019-0134 2 – https://www.cdc.gov/medicationsafety/adult_adversedrugevents.html 3 – https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-14-73 4 – https://pubmed.ncbi.nlm.nih.gov/24798722/ 5 – https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling 6 – https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255642 7 – https://www.reuters.com/article/us-bristol-myers-sanofi-plavix-idUSKBN2AF1YI 8 – https://www.einnews.com/pr_news/560810526/pharmacogenomics-market-is-estimated-to-reach-usd-11-97-billion-by-2028-emergen-research#:~:text=RESEARCH%20%2D%20EIN%20Presswire-,Pharmacogenomics%20Market%20is%20estimated%20to%20reach,billion%20by%202028%3A%20EMERGEN%20RESEARCH&text=Pharmacogenomics%20Market%20trends%20%E2%80%93%20Growing%20demand%20for%20personalized%20therapy
All TreatGx users now have access to the updated treatment algorithm for Migraine Prophylaxis. This update accounts for revisions made to existing clinical guidelines and will help health care providers select the safest and most effective medications with their patients. The…